Strs Ohio Buys New Position in Option Care Health, Inc. $OPCH

Key Points

• Strs Ohio made a new investment in Option Care Health, acquiring 18,200 shares worth approximately $636,000 in the first quarter.
• Option Care Health reported a net revenue of $1.42 billion for the last quarter, exceeding analyst expectations of $1.35 billion, and had an earnings per share (EPS) of $0.41.
• The stock has an average target price of $35.75 and is rated as a "Moderate Buy" by analysts, with multiple firms raising their target prices on shares.

Strs Ohio bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 18,200 shares of the company's stock, valued at approximately $636,000.

Other institutional investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. increased its stake in Option Care Health by 1,492.9% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock valued at $31,000 after purchasing an additional 836 shares in the last quarter. Brooklyn Investment Group increased its stake in Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after purchasing an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio increased its stake in Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after purchasing an additional 332 shares in the last quarter. Bessemer Group Inc. increased its stake in Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares in the last quarter. Finally, Wealthquest Corp bought a new stake in Option Care Health during the 1st quarter valued at $66,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Insiders Place Their Bets

In other Option Care Health news, Director Timothy P. Sullivan bought 20,000 shares of the business's stock in a transaction on Thursday, August 21st. The stock was purchased at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the transaction, the director directly owned 49,229 shares of the company's stock, valued at $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the business's stock in a transaction on Wednesday, August 20th. The shares were acquired at an average price of $27.15 per share, with a total value of $977,400.00. Following the transaction, the director directly owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 59,411 shares of company stock worth $1,627,576 over the last quarter. 0.64% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Barrington Research reiterated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research note on Tuesday. JMP Securities upped their target price on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Finally, Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Eight research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Stock Performance

NASDAQ:OPCH traded down $0.81 on Tuesday, reaching $27.86. 1,816,257 shares of the company's stock were exchanged, compared to its average volume of 1,857,214. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The firm has a market cap of $4.52 billion, a price-to-earnings ratio of 22.29, a P/E/G ratio of 1.72 and a beta of 0.83. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The stock has a fifty day simple moving average of $28.79 and a 200-day simple moving average of $31.17.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company's quarterly revenue was up 15.4% on a year-over-year basis. During the same quarter last year, the business earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.